MedPath

Perphenazine

Perphenazine Tablets, USP

Approved
Approval ID

2d821387-4b4f-4fe3-825e-750f49755baf

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 28, 2010

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Perphenazine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-415
Application NumberANDA089685
Product Classification
M
Marketing Category
C73584
G
Generic Name
Perphenazine
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 27, 2008
FDA Product Classification

INGREDIENTS (1)

perphenazineActive
Quantity: 8 mg in 1 1
Code: FTA7XXY4EZ
Classification: ACTIB

Perphenazine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-141
Application NumberANDA089684
Product Classification
M
Marketing Category
C73584
G
Generic Name
Perphenazine
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 27, 2008
FDA Product Classification

INGREDIENTS (1)

perphenazineActive
Quantity: 4 mg in 1 1
Code: FTA7XXY4EZ
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Perphenazine - FDA Drug Approval Details